Boxplots display the median (as the central tendency) and the interquartile range (25th to 75th percentiles) as the bottom and top edges of the box. by Manal Ali Ahmad (16868808)

Subjects:

RT-qPCR evaluation of MYD88, NLRP3, and NFκβ in GA 18.5 pup brains. by Adrienne J. Bradley (20861948)

Subjects:

AO/EtBr Staining of Cancer cell lines: <i>To check whether vitamin D3 promoted cell death in cancer cells, a dual staining protocol was implemented as detailed in the methods secti... by Vidya G. Bettada (22208808)

The levels of TBARS product in thalassemia red blood cells treated with 6-shogaol-rich ginger extract at concentrations of 50, 100, and 200 µg/mL and ascorbic acid (AA) at concentr... by Hataichanok Chuljerm (19144293)

Subjects:

Data Sheet 1_Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patients.pdf by Nancy Hilda Joseph (21837314)

“…</p>Results<p>Although Citrullinated Histone H3 and myeloperoxidase, did not show any difference in their levels, the NET marker elastase had significantly reduced circulatory levels in the tuberculosis group with SARS-CoV IgG positivity compared to tuberculosis group without SARS-CoV-2 IgG positivity.…”

Feeding and starvation affect the proportion and cell cycle activity of Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

“…<b>(C, D)</b> Intensity measures of pRPS6 bands relative to the Actin control protein show that Rapamycin (C) and AZD-8055 (D) led to a decrease of phosphorylated RPS6 levels. <i>n</i> = 3–5 technical replicates from one biological replicate with pools of 50 Rapamycin-, AZD-8055- or 0,2% DMSO-treated polyps. …”

Maps of alcohol-induced crude rates in the United States at the county level for 1999, 2021, 2024. by Tony Wong (779773)

Subjects:

Dynamics and functional role of TOR signaling during cell cycle re-entry in Vasa2+/Piwi1+ cells after refeeding. by Eudald Pascual-Carreras (12115380)

Data from qPCR analysis of hemolymph from included clams. by Rachael M. Giersch (22331947)

Subjects:

The weekly content of the 8-week training program. by Burhan Demirkıran (21601740)

Subjects:

Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

HRV Values. by Burhan Demirkıran (21601740)

Subjects:

Changes in subcutaneous fat thickness and muscle mass (Approximately here). by Burhan Demirkıran (21601740)

Subjects:

Data from qPCR analysis of eDNA and matching hemolymph timepoints. by Rachael M. Giersch (22331947)

Subjects:

Characteristics and outcomes from clams with MarBTN and control healthy clams. by Rachael M. Giersch (22331947)

Subjects:

HRV values (Approximately here). by Burhan Demirkıran (21601740)

Subjects:

Trial Design (Approximately Here). by Burhan Demirkıran (21601740)

Subjects:

Anecdotal case of regression in a clam with naturally acquired BTN. by Rachael M. Giersch (22331947)

Subjects:

MarBTN-specific eDNA detection in each clam that was followed for MarBTN in hemolymph and eDNA. by Rachael M. Giersch (22331947)

Subjects: